Endothelial cell processing and alternatively spliced transcripts of factor VIII: Potential implications for coagulation cascades and pulmonary hypertension

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Shovlin, Claire L ^a,b   Angus, Gillian ^b   Manning, Richard A ^b   Okoli, Grace N ^a   Govani, Fatima S ^a   Elderfield, Kay ^b   Birdsey, Graeme M ^a   Mollet, Inês G ^d   Laffan, Michael A ^b,c   Mauri, Francesco A ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; VON WILLEBRAND FACTOR; ISOPROTEIN;

ARTICLE; BLOOD CLOTTING; CELL SURFACE; CLINICAL ASSESSMENT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DATA MINING; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; FLOW CYTOMETRY; GENE SEQUENCE; GENETIC TRANSCRIPTION; HEAVY CHAIN; HEMOPHILIA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; LUNG PARENCHYMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLICEOSOME; TRANSCRIPTION INITIATION SITE; WEIBEL PALADE BODY; ALTERNATIVE RNA SPLICING; CELL CULTURE; CYTOLOGY; GENETICS; LUNG; METABOLISM; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; VASCULARIZATION;

ALTERNATIVE SPLICING; BASE SEQUENCE; BLOOD COAGULATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; FACTOR VIII; FLOW CYTOMETRY; HUMANS; HYPERTENSION, PULMONARY; IMMUNOHISTOCHEMISTRY; LUNG; MICROSCOPY, CONFOCAL; PROTEIN ISOFORMS; PULMONARY ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; VON WILLEBRAND FACTOR;

EID: 77949347401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009154     Document Type: Article

References (48)

1. Dahlbäck B (2000) Blood coagulation. Lancet 355: 1627-1632.
2. Mann KG, Butenas S, Brummel K (2003) The dynamics of thrombin formation. Arterioscler Thromb Vasc Biol 23: 17-25.
3. Mannucci PM, Tuddenham EGD (2001) The hemophilias-from royal genes to gene therapy. N Engl J Med 344: 1773-1779.
4. Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, et al. (2000) High plasma concentration of Factor VIIIc is a major risk factor for venous thromboembolism. Thrombosis and Haemostasis 83: 5-9.
5. Kyrle PA, Eichinger S (2003) The risk of recurrent venous thromboembolism: the Austrian study on recurrent venous thromboembolism. Wien Klin Wochenschr 115: 471-474.
6. House of Commons Select Committee on Health Second report (2005) The prevention of venous thromboembolism in hospitalised patients. Available: http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/99/9906.htm.
7. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, et al. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34: 1219-63.
8. Pengo V, Lensing AWA, Prins MH, Marchiori A, Davidson BL, et al. (2004) Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. New Engl J Med 350: 2257-2264.
9. Bonderman D, Turecek PL, Jakowitsch J, Welterman A, Adlbrecht C, et al. (2003) High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 90: 372-376.
10. Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, et al. (2000) Thrombotic risk factors in pulmonary hypertension. Eur Respir J 15: 395-399.
11. Kaufman RJ, Wasley LC, Davies MV, Wise RJ, Israel DI, et al. (1989) Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in chinese hamster ovary cells. Mol Cell Biol 9: 1233-1242.
12. Bontempo FA, Lewis JH, Gorenc TJ, Spero JA, Ragni MV, et al. (1987) Liver transplantation in hemophilia A. Blood 69: 1721-1724.
13. Hollestelle MJ, Thinnes T, Crain K, Stiko A, Kruijt JK, et al. (2001) Tissue distribution of factor VIII gene expression in vivo - a closer look. Thromb Haemost 86: 855-861.
14. Webster WP, Zukoski CF, Hutchin P, Reddick RL, Mandel SR, et al. (1971) Plasma factor VIII synthesis and control as revealed by canine organ transplantation. Am J Physiol 220: 1147-1154.
15. Shovlin CL, Sulainam NL, Govani FS, Jackson JE, Begbie ME (2007) Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism. Thromb Haemost 98: 1031-1039.
16. Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, et al. (2008) Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 63: 259-266.
17. Shovlin CL, Tighe HC, Davies RJ, Gibbs JSR, Jackson JE (2008) Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. Eur Resp J 32: 162-169.
18. Weibel ER (1973) Morphological basis of alveolar-capillary gas exchange. Physiological Reviews 53: 419-495.
19. Jacquemin M, Neyrinck A, Hermanns MI, Lavend'homme R, Rega F, et al. (2006) FVIII production by human lung microvascular endothelial cells. Blood 108: 515-517.
20. Pipe SW (2005) The promise and challenges of bioengineered recombinant clotting factors. J Thromb Haemost 3: 1692-1701.
21. Becker S, Simpson JC, Pepperkok R, Heinz S, Herder C, et al. (2004) Confocal microscopy analysis of native full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells. Thromb Haemost 92: 23-35.
22. Pipe SW (2009) Functional roles of the factor VIII B domain. Hemophilia 15: 1187-96.
23. Rotblat F, O'Brien DP, O'Brien FJ, Goodall AH, Tuddenham EG (1985) Purification of human factor VIII:C and its characterisation by Western Blotting using monoclonal antibodies. Biochemistry 24: 4294-4300.
24. Bartlett A, Dormandy KM, Hawkey CM, Stableforth P, Voller A (1976) Factor-VIII-related antigen: measurement by enzyme immunoassay. Br Med J 1 (6016): 994-996.
25. Pruitt KD, Tatusova T, Maglott DR (2007) NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res 35: D61-65.
26. ExonMine. Available: http://www.imm.fm.ul.pt/exonmine/.
27. Kent WJ (2002) BLAT-the BLAST-like alignment tool. Genome Res 12: 656-664.
28. Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, et al. (2004) The UCSC Table Browser data retrieval tool. Nucleic Acids Res 32: D493-D496.
29. UCSC Genome Browser. Available: http://genome.ucsc.edu/.
30. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Wheeler DL (2008) Genbank. Nucleic Acids Res 36: D25-D30.
31. Weibel ER, Palade GE (1964) New cytoplasmic components in arterial endothelia. J Cell Biol 23: 101-112.
32. Figueiredo MS, Brownlee GG (1995) cis-Acting elements and transcription factors involved in the promoter activity of the human Factor VIII gene. J Biol Chem 20: 11828-11838.
33. McGlynn LK, Mueller CR, Begbie M, Notley CR, Lillicrap D (1996) Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the Factor VIII gene. Mol Cell Biol 16: 1936-1945.
34. Jaffe EA, Hoyer LW, Nachman RL (1973) Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 52: 2757-2764.
35. Jaffe EA (1975) Synthesis of factor VIII antigen by cultured human endothelial cells. Ann N Y Acad Sci 240: 62-69.
36. Jaffe EA (1982) Synthesis of factor VIII by endothelial cells. Ann N Y Acad Sci 401: 163-170.
37. van den Biggelaar M, Bierings R, Storm G, Voorberg J, Mertens K (2007) Requirements for cellular co-trafficking of factor VIII and von Willebrand factor to Weibel-Palade bodies. J Thromb Haemost 5: 2235-42.
38. van den Biggelaar M, Bouwens EA, Kootstra NA, Hebbel RP, Voorberg J, et al. (2009) Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells. Haematologica 94: 670-678.
39. MacGregor IR, Roberts EM, Prowse CV, Broomhead AF, Ozolins M, et al. (1988) Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects. Thromb Haemost 59: 34-39.
40. Peacock A, Simonneau G, Rubin L (2006) Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 3: 608-614.
41. Hoeper MH, Meyer E, Simonneau G, Rubin LJ (2006) Chronic thromboembolic pulmonary hypertension. Circulation 113: 2011-2020.
42. Brinkman HJ, van Mourik JA, Mertens K (2008) Persistent factor VIII-dependent factor X activation on endothelial cells is independent of von Willebrand factor. Blood Coagul Fibrinolysis 19: 190-196.
43. Kaufman RJ, Wasley LC, Dorner AJ (1988) Synthesis, processing and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 263: 6352-6362.
44. Blencowe BJ (2006) Alternative splicing: new insights from global analyses. Cell 126: 37-47.
45. Hoeben RC, Fallaux FJ, Cramer SJ, van den Wollenberg DJM, van Ormondt H, et al. (1995) Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region. Blood 85: 2447-2454.
46. Plantier JL, Rodriguez MH, Enjolras N, Attali O, Négrier C (2001) A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII. Thromb Haemost 86: 596-603.
47. Xing Y, Lee CJ (2005) Evidence of functional selection pressure for alternative splicing events that accelerate evolution of protein subsequences. Proc Natl Acad Sci U S A 102: 13526-13531.
48. Bagnall RD, Ayres KL, Green PM, Gianelli F (2005) Gene conversion and evolution of Xq28 duplicons involved in recurring inversions causing severe haemophilia A. Genome Research 15: 214-223.